Portfolio (Quarterly)
Guide ↗
Davern Capital Partners, LP
· CIK 0002003147| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PFE | PFIZER INC | Healthcare | 1,593,942.0 | $44.8M | 12.28% | -448K | -21.9% | $28.08 | -8.3% |
| 2 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 44,800.0 | $34.6M | 9.49% | -8K | -14.5% | $772.64 | -17.0% |
| 3 | INSM | INSMED INC | Healthcare | 182,562.0 | $29.9M | 8.19% | NEW | — | $163.52 | -33.7% |
| 4 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 386,903.0 | $29.1M | 7.97% | +148K | +62.2% | $75.09 | +1.3% |
| 5 | NTRA | NATERA INC | Healthcare | 143,966.0 | $28.8M | 7.90% | +65K | +83.0% | $199.99 | +0.9% |
| 6 | BNTX | BIONTECH SE | Healthcare | 305,055.0 | $27.1M | 7.44% | -66K | -17.8% | $88.88 | +3.5% |
| 7 | ARGX | ARGENX SE | Healthcare | 35,045.0 | $25.6M | 7.02% | -640.0 | -1.8% | $730.25 | +10.3% |
| 8 | LLY | ELI LILLY & CO | Healthcare | 27,279.0 | $25.1M | 6.88% | +19K | +228.4% | $919.77 | +16.9% |
| 9 | RPRX | ROYALTY PHARMA PLC | Healthcare | 520,009.0 | $24.9M | 6.84% | -321K | -38.1% | $47.97 | +12.1% |
| 10 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 873,398.0 | $24.2M | 6.64% | -155K | -15.1% | $27.70 | +7.6% |
| 11 | LEGN | LEGEND BIOTECH CORP | Healthcare | 1,314,748.0 | $23.8M | 6.52% | +258K | +24.4% | $18.09 | +63.9% |
| 12 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 447,153.0 | $12.1M | 3.32% | +237K | +112.3% | $27.09 | +12.8% |
| 13 | ABVX | ABIVAX SA | Healthcare | 78,125.0 | $8.7M | 2.39% | +30K | +61.1% | $111.35 | +13.2% |
| 14 | GENB | GENERATE BIOMEDICINES INC | Financial Services | 591,800.0 | $7.4M | 2.03% | NEW | — | $12.50 | +8.5% |
| 15 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 261,200.0 | $6.5M | 1.79% | NEW | — | $25.01 | +11.5% |
| 16 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 126,461.0 | $6.1M | 1.67% | NEW | — | $48.20 | -19.1% |
| 17 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 302,457.0 | $5.9M | 1.62% | +41K | +15.6% | $19.56 | -12.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.0%
Financial Services
2.0%